SCOR (SCR) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
30 Oct, 2026Executive summary
Q3 net income was EUR 206m; 9M net income was EUR 603m, or EUR 615m adjusted for the own-share option mark-to-market impact.
Q3 annualized ROE was 20.4%; 9M annualized ROE was 18.9%, or 19.3% adjusted.
Economic Value reached EUR 8.9bn, up 11.9% at constant economics in 9M; solvency ratio rose 6 points to 221%.
Financial highlights
Q3 insurance revenue was EUR 3,757m, up 1.2% YoY; 9M revenue was EUR 11,196m, down 3.4%.
Q3 operating result was EUR 321m, up 2.5% YoY; 9M operating result was EUR 942m, down 3.7%.
Q3 EPS was EUR 1.16; 9M EPS was EUR 3.37, or EUR 3.44 adjusted for the own-share option impact.
9M operating cash flow was EUR 883m; Q3 operating cash flow was EUR 559m.
Outlook and guidance
Forward 2026 targets include P&C combined ratio below 87%, L&H insurance service result of ~EUR 0.4bn p.a., regular income yield of 3.4%–3.8%, and economic value growth above 12%.
Management expects continued P&C buffer building; strong attritional performance remains supportive, while quarterly reserve additions were not quantified.
The new strategic plan will be presented on December 3; assumptions account for further P&C market softening.
Solvency II review impact guidance remains 10%–15%, with an update planned for Investor Day; L&H cash flow is expected to be neutral or positive in 2026.
Latest events from SCOR
- Record results, strong governance, and all resolutions approved amid ongoing strategic transformation.SCR
AGM 2026 - Resilient 2024 results, robust governance, and Forward 2026 strategy drive strong approvals.SCR
AGM 2025 - H1 2026 net income EUR 409m, ROE 19%, solvency 220%, P&C combined ratio 79.5%.SCR
Q2 2026 - Q1 2026 net income was EUR 225m, ROE 21.1%–21.7%, and solvency ratio rose to 220%.SCR
Q1 2026 - Q2 net income EUR 226m, H1 EUR 425m, ROE 22.6%, solvency 210%, strong P&C and L&H.SCR
Q2 2025 - Forward 2026 targets 9% value growth, >12% ROE, higher-margin L&H, and robust reserves.SCR
Investor Day 2024 - Strong P&C and investments offset by L&H review one-offs; solvency robust at 203%.SCR
Q3 2024 - Q2 2024 net loss driven by L&H review, but P&C and solvency remain strong.SCR
Q2 2024 - Q1 2025 net income was EUR 200m, with 18.3% ROE and strong P&C and investment results.SCR
Q1 2025